Diffuse Gastric Adenocarcinoma
📧 Sign up to get email alerts when something new happens for Diffuse Gastric Adenocarcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-08-04Clinical Trial Update: Akt Inhibitor MK2206 in Treating Patients With Advanced Gastric or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial results for the Akt inhibitor MK-2206 in advanced gastric and gastroesophageal junction cancers have been posted.
-
CLINICAL_TRIALS trial_result · 2013-06-04Clinical Trial Update: Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma [Phase 2]
This Phase 2 trial evaluated a triplet regimen of irinotecan, cisplatin, and bevacizumab in patients with unresectable or metastatic gastric…